IT1109273B - Procedimento per preparare composizioni farmaceutiche a base di amossicillina - Google Patents

Procedimento per preparare composizioni farmaceutiche a base di amossicillina

Info

Publication number
IT1109273B
IT1109273B IT51415/78A IT5141578A IT1109273B IT 1109273 B IT1109273 B IT 1109273B IT 51415/78 A IT51415/78 A IT 51415/78A IT 5141578 A IT5141578 A IT 5141578A IT 1109273 B IT1109273 B IT 1109273B
Authority
IT
Italy
Prior art keywords
procedure
pharmaceutical compositions
based pharmaceutical
preparing amoxicillin
amoxicillin
Prior art date
Application number
IT51415/78A
Other languages
English (en)
Other versions
IT7851415A0 (it
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1109273(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IT7851415A0 publication Critical patent/IT7851415A0/it
Application granted granted Critical
Publication of IT1109273B publication Critical patent/IT1109273B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT51415/78A 1977-10-11 1978-10-09 Procedimento per preparare composizioni farmaceutiche a base di amossicillina IT1109273B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (2)

Publication Number Publication Date
IT7851415A0 IT7851415A0 (it) 1978-10-09
IT1109273B true IT1109273B (it) 1985-12-16

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
IT51415/78A IT1109273B (it) 1977-10-11 1978-10-09 Procedimento per preparare composizioni farmaceutiche a base di amossicillina

Country Status (24)

Country Link
US (2) US4441609A (it)
JP (1) JPS5476831A (it)
AU (1) AU525089B2 (it)
BE (1) BE870988A (it)
CA (1) CA1105385A (it)
CH (1) CH642258A5 (it)
DE (1) DE2843318A1 (it)
FR (1) FR2405711A1 (it)
GB (1) GB2005538B (it)
HK (1) HK73785A (it)
IE (1) IE47450B1 (it)
IL (1) IL55660A (it)
IT (1) IT1109273B (it)
JO (1) JO984B1 (it)
KE (1) KE3525A (it)
MT (1) MTP836B (it)
MY (1) MY8500996A (it)
NL (1) NL190631B (it)
NZ (1) NZ188497A (it)
PL (1) PL210174A1 (it)
PT (1) PT68600A (it)
SE (2) SE435899B (it)
SG (1) SG34985G (it)
ZA (1) ZA785682B (it)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
NL7601227A (nl) * 1975-02-07 1976-08-10 Glaxo Lab Ltd Werkwijze ter bereiding van een nieuw antibioti- cum.
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
GR70283B (it) 1979-10-02 1982-09-03 Beecham Group Ltd
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
ES2039226T3 (es) * 1986-12-30 1993-09-16 American Cyanamid Company Procedimiento para preparar composiciones que contienen policarbofil.
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
EP0879772B1 (en) * 1994-08-05 2002-06-12 Smithkline Beecham Plc Pharmaceutical substances in containers and method of dessicating them
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
ATE208618T1 (de) * 1995-09-07 2001-11-15 Smithkline Beecham Corp Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
KR100499812B1 (ko) * 1997-02-14 2005-07-08 스미스클라인 비참 코포레이션 아목시실린 및 클라불라네이트를 포함하는 약제학적 제형
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
CA2383522C (en) * 1999-08-16 2011-12-06 Revaax Pharmaceuticals, Llc Neurotherapeutic composition and method
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2003254914A1 (en) * 2002-08-12 2004-03-03 Kyowa Hakko Kogyo Co., Ltd. Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CA2691197C (en) 2007-06-21 2013-03-12 Gen-Probe Incorporated Instrument and receptacles for use in performing processes
KR20100101574A (ko) * 2007-10-26 2010-09-17 렉산 파마슈티컬스, 인코포레이티드 클라불란산의 제약 제제
AU2010242948A1 (en) * 2009-04-29 2011-11-24 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus

Also Published As

Publication number Publication date
MTP836B (en) 1979-05-11
SG34985G (en) 1985-11-15
SE7810591L (sv) 1979-04-12
US4441609A (en) 1984-04-10
JPS5476831A (en) 1979-06-19
US4301149A (en) 1981-11-17
PT68600A (en) 1978-10-01
SE435899B (sv) 1984-10-29
SE451668B (sv) 1987-10-26
NL190631B (nl) 1994-01-03
BE870988A (fr) 1979-04-03
JPS6341886B2 (it) 1988-08-19
MY8500996A (en) 1985-12-31
DE2843318A1 (de) 1979-04-12
NZ188497A (en) 1981-05-01
SE8107592L (sv) 1981-12-17
AU525089B2 (en) 1982-10-21
FR2405711A1 (fr) 1979-05-11
PL210174A1 (it) 1980-08-11
CH642258A5 (de) 1984-04-13
JO984B1 (en) 1979-12-01
KE3525A (en) 1985-05-31
GB2005538B (en) 1982-05-26
IL55660A (en) 1981-09-13
CA1105385A (en) 1981-07-21
IE782019L (en) 1979-04-11
HK73785A (en) 1985-10-04
IL55660A0 (en) 1978-12-17
IE47450B1 (en) 1984-03-21
AU4050678A (en) 1980-04-17
FR2405711B1 (it) 1982-10-29
IT7851415A0 (it) 1978-10-09
ZA785682B (en) 1979-09-26
GB2005538A (en) 1979-04-25
NL7810176A (nl) 1979-04-17

Similar Documents

Publication Publication Date Title
IT1109273B (it) Procedimento per preparare composizioni farmaceutiche a base di amossicillina
IT1143089B (it) Procedimento per preparare composizioni farmaceutiche attivate
GB2003028B (en) Pharmaceutical compositions
IT1101294B (it) Procedimento per preparare ntirodiarilammine
ES491064A0 (es) Procedimiento de obtencion de composiciones liquidas, cura- bles a base de poliesteres
IT1097295B (it) Procedimento per preparare p-benzochinone
SE7812820L (sv) Forfarande for framstellning av resolformningskompositioner
IT1092403B (it) Procedimento per preparare protocatecualdeide
IT1071469B (it) Procedimento per preparare composizioni ad attivita' rodenticida
IT1095377B (it) Composizione farmaceutica
AR219549A1 (es) Procedimiento para preparar rifampicina
IT7849938A0 (it) Composizioni farmaceutiche
GB2008403B (en) Pharmaceutical compositions
MW478A1 (en) Pharmaceutical compositions
IT1089268B (it) Procedimento per preparare metil-isocianato
IT1105084B (it) Procedimento per preparare derivati di tienopiridine
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
IT7851965A0 (it) Composizioni a base di amminoalcossiammine
SE7705851L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE7803456L (sv) Forfarande for framstellning av en farmaceutisk komposition
GB2008408B (en) Pharmaceutical compositions
IT7852414A0 (it) Composizione farmaceutica antidiarroica e procedimento per prepararla
FI781507A7 (fi) Farmaceutiska kompositioner
IT1098369B (it) Procedimento per la preparazione di un ciclopentendione
IT1155796B (it) Procedimento per preparare tetralchiltiuram-bisolfuri

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 100

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 100, 19920415; BEECHAM GROUP PLC

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971031